XML 51 R36.htm IDEA: XBRL DOCUMENT

Business Segments and Geographic Information (Tables)

12 Months Ended

Sep. 26, 2020

Segment information for fiscal 2020, 2019, and 2018 was as follows:


	Years ended
	September 26, 2020		September 28, 2019		September 29, 2018
Total revenues:
Diagnostics	$	2,102.1	$	1,205.5	$	1,147.4
Breast Health	1,151.9		1,314.2		1,218.2
GYN Surgical	376.1		$	437.2	422.0
Skeletal Health	81.0		94.8		91.2
Medical Aesthetics	65.3		315.6		339.1
	$	3,776.4	$	3,367.3	$	3,217.9
Operating income (loss):
Diagnostics	$	929.7	$	163.1	$	145.5
Breast Health	192.8		399.3		399.7
GYN Surgical	42.0		99.2		58.3
Skeletal Health	(2.4)		(4.2)		3.3
Medical Aesthetics	(57.1)		(781.2)		(844.7)
	$	1,105.0	$	(123.8)	$	(237.9)
Depreciation and amortization:
Diagnostics	$	237.3	$	246.6	$	257.3
Breast Health	48.8		36.8		22.7
GYN Surgical	85.1		87.7		91.6
Skeletal Health	0.7		0.6		0.6
Medical Aesthetics	4.1		91.4		108.1
	$	376.0	$	463.1	$	480.3
Capital expenditures:
Diagnostics	$	110.7	$	59.2	$	57.7
Breast Health	22.4		18.3		14.8
GYN Surgical	17.9		15.7		13.1
Skeletal Health	0.2		1.2		3.3
Medical Aesthetics	1.4		7.0		9.4
Corporate	3.8		7.7		7.3
	$	156.4	$	109.1	$	105.6
Identifiable assets:
Diagnostics	$	2,161.4	$	2,276.6	$	2,442.9
Breast Health	1,200.9		1,127.8		972.4
GYN Surgical	1,438.7		1,328.6		1,414.9
Skeletal Health	38.9		27.3		30.3
Medical Aesthetics	—		159.3		913.3
Corporate	2,355.9		1,522.5		1,457.1
	$	7,195.8	$	6,442.1	$	7,230.9

Revenues by geography as a percentage of total revenues were as follows:

The Company’s property, plant and equipment, net were geographically located as follows: